Top Performing Stocks To Watch Right Now


Novavax’s (NASDAQ:NVAX) Covid-19 vaccine candidate may still be far from entering the U.S. market. But that’s not a reason to skip out on NVAX stock. Why? While it’s not one of the front-runners, this company is still not out of the running domestically.

Source: Ascannio/Shutterstock.com

More specifically, its vaccine could still find success in the possible booster shot segment of the space. Plus, some of the unique products working their way through the company’s pipeline — like a combination Covid-19 and flu vaccine — could end up being winners as well.

However, these U.S.-focused catalysts may not even have to play out for NVAX stock to keep performing. Further news of overseas deals points to Novavax finding big commercial success with its candidate. After this year’s strong performance, there’s a path for shares to make another leap higher in 2022. All it needs to do is hit earnings projections in order for investors to give it a higher valuation.

Top Performing Stocks To Watch Right Now: AllianzGI NFJ Dividend, Interest & Premium Strategy Fund(NFJ)


NFJ Dividend, Interest& Premium Strategy Fund (the Fund) is a diversified closed-end management investment company. The Fund’s primary investment objective is to seek current income and gains, with a secondary objective of long-term capital appreciation. The Fund invests in a diversified portfolio of dividend-paying common stocks and income producing convertible securities. It may also write (sell) call options on equity indexes.

The Fund invests in various industries, including agriculture, airlines, banking, chemicals, pharmaceuticals, oil and gas, telecommunications, commercial services, diversified financial services, electric, computers, hotel/gaming and media. Allianz Global Investors Fund Management LLC is the investment manager of the Fund. Allianz Global Investors Fund Management LLC is an indirect wholly owned subsidiary of Allianz Global Investors of America L.P. The Fund’s sub-advisors are NFJ Investment Group L.P, Nicholas-Applegate Capital Management and Oppenheimer Capital LLC.


Advisors’ Opinion:

  • [By Stephan Byrd]

    We Are One Seven LLC bought a new stake in shares of Allianzgi NFJ Dividend int & Prm Stgy Fd (NYSE:NFJ) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 29,490 shares of the investment management company’s stock, valued at approximately $386,000.

  • [By Ethan Ryder]

    News coverage about Allianzgi NFJ Dividend int & Prm Stgy Fd (NYSE:NFJ) has trended somewhat positive recently, according to Accern. The research group identifies negative and positive news coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Allianzgi NFJ Dividend int & Prm Stgy Fd earned a daily sentiment score of 0.22 on Accern’s scale. Accern also assigned news articles about the investment management company an impact score of 48.4440755158662 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

Top Performing Stocks To Watch Right Now: Blackhawk Network Holdings, Inc.(HAWK)


Blackhawk is a leading prepaid payment network utilizing proprietary technology to offer a broad range of prepaid gift, telecom and debit cards, in physical and electronic forms, as well as related prepaid products and payment services in the United States and 23 other countries. We were founded in 2001 as a division of Safeway Inc. (Safeway) which later merged with Albertsons Holdings LLC in January 2015 (referred to hereinafter as “Albertsons/Safeway”). We were incorporated in Delaware as Blackhawk Network, Inc. in 2006 and changed our name to Blackhawk Network Holdings, Inc. later that year. In April 2013, we completed our initial public offering (the Offering) for the sale of 11,500,000 shares of our Class A common stock, all of which shares were sold by existing stockholders, primarily Safeway. On April 14, 2014, Safeway distributed its remaining 37.8 million shares of our Class B common stock to Safeway shareholders (the Spin-Off).   Advisors’ Opinion:

  • [By Max Byerly]

    Shares of Blackhawk Network Holdings (NASDAQ:HAWK) have been given a consensus rating of “Hold” by the eighteen ratings firms that are presently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, fourteen have assigned a hold recommendation and two have given a buy recommendation to the company. The average twelve-month target price among brokers that have covered the stock in the last year is $44.75.

Top Performing Stocks To Watch Right Now: Seaspan Corporation(SSW)


Seaspan Corporation, incorporated on May 3, 2005, is an independent charter owner and manager of containerships. The Company charters pursuant to long-term, fixed-rate time charters with various container liner companies. The Company operates a fleet of approximately 90 containerships. The Company’s operating vessels include YM Wish, YM Wellhead, YM Witness, COSCO Glory, MOL Emissary, MOL Efficiency, CSCL Brisbane, Jakarta Express, CSCL Manzanillo and Guayaquil Bridge.

The Company’s over four 4,800 20-foot equivalent unit (TEU) vessels are chartered by Mediterranean Shipping Company S.A. (MSC) under bareboat charters, which are contracts for the use of a vessel for a fixed period of time at a specified amount. The Company is responsible for the operation and management of vessel, including maintaining the vessel, periodic dry-docking, cleaning and painting and performing work required by regulations under each of the time charters. The Company also provides limited ship management services to Dennis R. Washington’s personal vessel owning companies, and ship management and construction supervision services to Greater China Intermodal Investments LLC (GCI).


Advisors’ Opinion:

  • [By Motley Fool Transcribing]

    Seaspan (NYSE:SSW) Q4 2018 Earnings Conference CallMarch 6, 2019 8:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Matthew DiLallo]

    Seaspan (NYSE:SSW) ended 2018 on a high note as it delivered record revenue, operating earnings, and cash flow for the fourth quarter, which pushed its full-year results to record levels as well. Driving that strong showing was the buyout of a joint venture, which significantly increased its fleet. On top of its strong financial results, Seaspan also shored up its balance sheet by closing several transactions with Fairfax Financial (NASDAQOTH:FRFHF), which is now its largest shareholder.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on SEASPAN Corp/SH SH (SSW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    SEASPAN Corp/SH SH (NYSE:SSW) was downgraded by equities researchers at Wells Fargo & Co from a “market perform” rating to an “underperform” rating in a research report issued on Friday, Marketbeat.com reports. They currently have a $6.00 price objective on the shipping company’s stock. Wells Fargo & Co’s target price would suggest a potential downside of 27.97% from the stock’s current price.

Top Performing Stocks To Watch Right Now: vTv Therapeutics Inc.(VTVT)


vTv Therapeutics Inc., a biopharmaceutical company, discovers, develops, and sells orally administered small molecule drug candidates worldwide. The company’s drug candidate for the treatment of Alzheimer’s disease comprise azeliragon (TTP488), an orally administered, small molecule antagonist targeting the receptor for advanced glycation endproducts, which is in Phase III clinical trials. Its type 2 diabetes drug candidates include TTP399, an orally administered, liver-selective glucokinase activator that has been completed Phase IIb clinical trials; and TTP273, an orally administered, non-peptide agonist that targets the glucagon-like peptide-1 receptor, which is in Phase II clinical trials. The company has a license and research agreement with Calithera Biosciences, Inc. to develop, and commercialize its hexokinase II inhibitors for therapeutics, prophylactic, preventative, or diagnostic use. vTv Therapeutics Inc. was founded in 2015 and is headquartered in High Point, North Carolina.

Leave a Reply

Your email address will not be published.